Drug trials for older people

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 2, 2012, Pages 152-157

  Lindley, Richard I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Aging; Frailty; Randomized controlled trials

Indexed keywords

AGE; AGED; AGING; CLINICAL TRIAL (TOPIC); DAILY LIFE ACTIVITY; DRUG EFFECT; HUMAN; REVIEW;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED; AGING; CLINICAL TRIALS AS TOPIC; HUMANS;

EID: 84856148716     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr065     Document Type: Article

References (26)

1. Cherubini A, Del Signore S, Ouslander J, Semla T, Michel J-P. Fighting against age discrimination in clinical trials. J Am Geriatr Soc. 2010;58:1791-1796.
2. McMurdo MET, Witham MD, Gillespie ND. Including older people in clinical research. BMJ. 2005;331:1036-1037. (Pubitemid 41597848)
3. Mitka M. Too few older patients in cancer trials. Experts say disparity affects research results and care. JAMA. 2003;290:27-28. (Pubitemid 37432859)
4. Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci. 2009;64:675-681.
5. Sousa RM, Ferri CP, Acosta D, et al. Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Lancet. 2009;374:1821-1830.
6. Perls T. Health and disease in people over 85. BMJ. 2009;339:b4715.
7. Anonymous. Australian Institute of Health and Welfare 2008. Residential Aged Care in Australia 2006-7: A Statistical Overview. Canberra, Australia: AIHW; 2008.
8. AIHW. Use of Health and Aged Care Services; Older Australia at a Glance. In: Welfare AIoHa, ed. Canberra, Australia: Australian Government.
9. Fries JF. Measuring and monitoring success in compressing morbidity. Ann Intern Med. 2003;139:455-459. (Pubitemid 38120876)
10. de Grey ADNJ. Compression of morbidity: the hype and the reality, part 1. Rejuvenation Res. 2006;9:1-2.
11. de Grey ADNJ. Compression of morbidity: the hype and the reality, part 2. Rejuvenation Res. 2006;9:167-168. (Pubitemid 43856804)
12. Murray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study [see comments]. Lancet. 1997;349:1347-1352. (Pubitemid 27197536)
13. Anonymous. Life Expectancy and Disability in Australia 1988 to 2003. Disability Series. Cat. no. DIS 47. In: Welfare AIoHa, ed.Canberra, Australia: AIHW; 2006.
14. Masaki KH, Schatz IJ, Burchfiel CM, et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation. 1998;98:2290-2295. (Pubitemid 28533848)
15. Mitnitski AB, Mogilner AJ, MacKnight C, Rockwood K. The mortality rate as a function of accumulated deficits in a frailty index. Mechanisms Ageing Develop. 2002;123:1457-1460. (Pubitemid 35341153)
16. Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age: a report based on the Framingham Data. Arch Intern Med. 1993;153:1065-1073. (Pubitemid 23135464)
17. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
18. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. [Erratum appears in Lancet. 2008 Jun 21;371(9630):2084]. [Erratum appears in Lancet. 2005 Oct 15-21;366(9494):1358]. Lancet. 2005;366:1267-1278.
19. Collerton J, Davies K, Jagger C, et al. Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ. 2009;339:b4904.
20. Prospective Studies Collaboration, Lewington S, Whitlock G, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829-1839.
21. Antithrombotic Trialists Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-1860.
22. Ridda I, Lindley R, MacIntyre RC. The challenges of clinical trials in the exclusion zone: the case of the frail elderly. Aust J Ageing. 2008;27:61-66.
23. Paasche-Orlow MK, Taylor HA, Brancati FL. Readability standards for informed-consent forms as compared with actual readability. N Eng J Med. 2003;348:721-726. (Pubitemid 36237042)
24. Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial. Br Med J. 2002;325:415-417. (Pubitemid 34969790)
25. Rockwood K, Stadnyk K, MacKnight C, et al. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353:205-206. (Pubitemid 29088034)
26. Ridda I, Macintyre CR, Lindley R, et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine. 2009;27:1628-1636.